Free, self-directed programs for continuing education credit.
Choosing the Best Genomic Tumor Test
Learn about the benefits and limitations of different genomic tumor test options for patients with cancer and how to determine the best test for each patient.
Access CME Module | Access CNE Module
Genomic (Somatic) Tumor Testing
Frequently Asked Questions: Large scale genomic tumor testing. Describes large-scale genomic tumor testing and discusses its benefits, risks, and limitations.
Indications for Germline Testing in Cancer Patients. Identifies genetic red flags to inform personal and family history risk assessment and genomic tumor test results that are suggestive of a germline variant.
Liquid Biopsy FAQ. Describes the benefits, risks and limitations of liquid biopsy.
Anatomy of Genomic Tumor Test Report. Annotated genomic tumor test report.
Comparing Somatic Cancer Panels. Provides information about how somatic tumor test offerings may differ among laboratories.
Frequently Asked Questions: PARP Inhibition Therapy. Provides an overview of PARP inhibition (PARPi) therapy.
PARP Inhibitors: Overview and Indications. Discusses FDA-approved indications for PARPi for maintenance therapy and cancer treatment as well as emerging uses under investigation.
Evaluating Immune Checkpoint Inhibition Biomarkers. Provides an overview of the benefits and limitations of commonly used immune checkpoint inhibition biomarkers.
Ordering and Interpreting PD-L1 Testing. Discusses which patients may benefit from PD-L1 testing and how to select and interpret tests for patients with different cancer types.
Communicating with Patients
Facilitating shared decision making about somatic tumor testing. Supports clinicians when communicating about the process, benefits, and limitations associated with somatic tumor testing.
Allow essential cookies
Required for basic site operations.
Allow analytics cookies
Used to analyze web traffic to improve the user experience.
Allow marketing cookies
Used to deliver personalized information and tailor communications.